Faculty Opinions recommendation of Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial.

Author(s):  
Mellar Davis
2019 ◽  
Vol 28 (10) ◽  
pp. 1978-1986
Author(s):  
Sujin Ann‐Yi ◽  
Kimberson Tanco ◽  
Cindy L. Carmack ◽  
Diane D. Liu ◽  
Swati Bansal ◽  
...  

1983 ◽  
Vol 1 (10) ◽  
pp. 635-639 ◽  
Author(s):  
N Colbert ◽  
V Izrael ◽  
J P Lotz ◽  
D Stoppa-Lyonnet ◽  
J M Vannetzel ◽  
...  

A double-blind trial to evaluate the antiemetic effects of adrenocorticotropic hormone (ACTH) in patients treated with cisplatin was performed. Thirty-seven adults with advanced cancer who were treated with cisplatin were randomly assigned to receive either synthetic long-acting ACTH (1 mg IM given 24 hours, 12 hours, and immediately preceding the administration of cisplatin) or a placebo given under the same conditions. All of the patients received chlorpromazine (50 mg IM) 30 minutes before cisplatin infusion. Patients receiving ACTH and chlorpromazine had significantly fewer episodes of vomiting (p less than 0.01) and shorter periods of nausea (p less than 0.02) than patients receiving placebo and chlorpromazine. Patients receiving ACTH and chlorpromazine were significantly more comfortable than patients receiving placebo and chlorpromazine. No important side effects were observed. ACTH may be an effective agent in preventing nausea and vomiting induced by cisplatin.


2007 ◽  
Vol 177 (4S) ◽  
pp. 35-35
Author(s):  
Gianluca Giannarini ◽  
Andrea Mogorovich ◽  
Girolamo Morelli ◽  
Maurizio De Maria ◽  
Francesca Manassero ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document